CO2 laser surgery for extensive, cauliflower-like anogenital condylomata acuminata:: Retrospective long-term study on 19 HIV-positive and 45 HIV-negative men

被引:17
作者
Carrozza, PM
Merlani, GM
Burg, G
Hafner, J
机构
[1] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland
[2] Univ Zurich Hosp, Dept Internal Med, Div Infect Dis, CH-8091 Zurich, Switzerland
关键词
condyloma acuminatum; human papillomavirus; men; CO2; laser; endoanal condyloma; cauliflower-like condyloma; recurrence;
D O I
10.1159/000065844
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Extensive 'cauliflower-like' condyloma acuminatum (CA) in males is commonly treated with CO2 laser surgery or with electrosurgery. Studies on the long-term outcome in this specific situation are scarce. Objectives: To determine the cure and recurrence rate in relation to the HIV status and endoanal location of lesions. To determine the complication rate and patient satisfaction. Methods: Questionnaire-based retrospective long-term study on 64 consecutive men (answer rate 60% or 64/107 addressed persons). The mean follow-up was 25 months (range 7-75). Results: The overall cure rate after 1 intervention was 67%. The cure rate in HIV-positive versus HIV-negative patients was 58 versus 71% (odds ratio = 1.79; p = 0.38). Endoanal versus perianal location was associated with a cure rate of 56 versus 84% (odds ratio = 4.06; p = 0.03). After a second treatment session, the cure rate increased to 79% or higher in all subgroups. Painful defecation for an average of 4-5 weeks was the main postoperative complaint. Severe complications were not seen or reported. Conclusions: The CO2 laser is a valuable and safe treatment to debulk extensive 'cauliflower-like' anogenital CA in males. The healing rate in HIV-positive patients is not significantly lower than in HIV-negative patients. Endoanal location of lesions is a risk factor for recurrence. Copyright (C) 2002 S. Karger AG, Basel.
引用
收藏
页码:255 / 259
页数:5
相关论文
共 26 条
[1]   TREATMENT OF EXTERNAL GENITAL WARTS COMPARING CRYOTHERAPY (LIQUID-NITROGEN) AND TRICHLORACETIC ACID [J].
ABDULLAH, AN ;
WALZMAN, M ;
WADE, A .
SEXUALLY TRANSMITTED DISEASES, 1993, 20 (06) :344-345
[2]  
Alam M, 2001, ARCH DERMATOL, V137, P337
[3]  
Armstrong DKB, 1996, GENITOURIN MED, V72, P103
[4]  
Beutner Karl R., 1997, American Journal of Medicine, V102, P28
[5]   Genital warts and their treatment [J].
Beutner, KR ;
Wiley, DJ ;
Douglas, JM ;
Tyring, SK ;
Fife, K ;
Trofatter, K ;
Stone, KM .
CLINICAL INFECTIOUS DISEASES, 1999, 28 :S37-S56
[6]  
CHRISTEN D, 1992, LANGENBECK ARCH CHIR, V377, P207
[7]   Self-administered topical 5% imiquimod cream for external anogenital warts [J].
Edwards, L ;
Ferenczy, A ;
Eron, L ;
Baker, D ;
Owens, ML ;
Fox, TL ;
Hougham, AJ ;
Schmitt, KA .
ARCHIVES OF DERMATOLOGY, 1998, 134 (01) :25-30
[8]   TREATING VAGINAL AND EXTERNAL ANOGENITAL CONDYLOMAS WITH ELECTROSURGERY VS CO2-LASER ABLATION [J].
FERENCZY, A ;
BEHELAK, Y ;
HABER, G ;
WRIGHT, TC ;
RICHART, RM .
JOURNAL OF GYNECOLOGIC SURGERY, 1995, 11 (01) :41-50
[9]   IMMUNOHISTOLOGY OF GENITAL WARTS IN DIFFERENT STAGES OF REGRESSION AFTER THERAPY WITH INTERFERON GAMMA [J].
FIERLBECK, G ;
SCHIEBEL, U ;
MULLER, C .
DERMATOLOGICA, 1989, 179 (04) :191-195
[10]   Treatment of external genital warts in men using 5% imiquimod cream applied three times a week, once daily, twice daily, or three times a day [J].
Fife, KH ;
Ferenczy, A ;
Douglas, JM ;
Brown, DR ;
Smith, M ;
Owens, ML .
SEXUALLY TRANSMITTED DISEASES, 2001, 28 (04) :226-231